Positive Results For New Diabetes Drug

Tresiba®: SWITCH 2 Study Meets Primary Endpoint

Sanofi-aventis New Type 2 Diabetes Drug, Lixisenatide, Shows Promise

Do In Vitro Assays Predict Drug Candidate Idiosyncratic Drug-Induced Liver Injury Risk? | Drug ...